Navigation Links
CUREXO Technology Corporation Announces 510(k) Submission to FDA for Total Knee Arthroplasty Application
Date:2/25/2009

SACRAMENTO, Calif., Feb. 20 /PRNewswire/ -- CUREXO Technology Corporation, pioneer in medical robotics and world leader in image-directed robotic products for orthopaedic applications, which is focused on marketing its robotic system, announced today that it has submitted a premarket notification 510(k) application to the U.S. Food and Drug Administration (FDA) for market clearance in the U.S. for use of its ROBODOC(R) Surgical System for Total Knee Arthroplasty (TKA).

The 510(k) application is used when there exist similar, previously-cleared technologies in the marketplace. This submission follows the company's recently cleared 510(k) for Total Hip Arthroplasty (THA) and will offer surgeons an accurate, precise, and reproducible surgical technique to prepare the joint during a knee replacement procedure. The process will allow surgeons to preoperatively plan their surgery in a 3-D virtual space and then execute the surgery exactly as planned in the operating theatre.

"We are very pleased to announce the submission of the TKA 510(k) application to the FDA, as it demonstrates that we are moving forward with achieving our goals of providing a world class multi-platform technology," said Brent D. Mittelstadt, President and CEO of CUREXO Technology Corporation. "We believe that because of our recent hip application clearance, receiving the TKA market clearance should be granted within a reasonable time frame. Offering this additional application will allow us to build upon relationships that we are establishing as we introduce the ROBODOC(R) Surgical System into the U.S. orthopaedic community," continued Mr. Mittelstadt.

About CUREXO Technology Corporation

CUREXO Technology Corporation develops, manufactures, and markets an image directed surgical robotic system for orthopaedic surgery. The ROBODOC(R) Surgical System includes two components; ORTHODOC(R), a computer workstation equipped with proprietary software for 3-D preoperative surgical planning, and the ROBODOC(R) Surgical Assistant, a computer-controlled surgical robot utilized for precise cavity and surface preparation for hip and knee replacement surgeries.

The ROBODOC(R) Surgical System has been cleared by the U.S. FDA for Total Hip Arthroplasty procedures; making it the only active robotic system cleared by the FDA for orthopaedic surgery. To date the system has been used in over 24,000 surgical procedures worldwide.

ROBODOC(R) and ORTHODOC(R) are registered trademarks of CUREXO Technology Corporation. For more information, visit www.robodoc.com.

    Contact:
    Ms. Sheila Shah
    Marketing Communications
    CUREXO Technology Corporation
    916 285 9943 X 510
    press@robodoc.com


'/>"/>
SOURCE CUREXO Technology Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CUREXO Technology Corporation Names Brent D. Mittelstadt as President & CEO
2. Quantum light beams good for fast technology
3. New Smart Technology Makes Patient Data Collection Easier, More Efficient
4. Align Technology Executive to Present at Upcoming Financial Conferences
5. Pioneer Surgical Technology Hires Vice President of New Business Development
6. Purdue researchers develop technology to detect cancer by scanning surface veins
7. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
8. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
9. Patent Reform Legislation Threatens Americas Leadership in Medical Technology Innovation
10. Stevens Health, Technology and Society roundtable: Sept. 19
11. Microbiotic technology developed for microinjection of zebrafish embryos
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... ... scientific laboratories. The assembly protocols involve many repetitive steps and often scientists require ... which enables the high-throughput needed, and results in a lower error rate and ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... of Gastrointestinal Oncology™ (SOGO™), a specialized continuing medical education conference for clinicians who ... at Intercontinental Time Square, New York. , The program will be led ...
(Date:3/28/2017)... ... March 28, 2017 , ... A recent Bellwether Education ... quality, the field must first improve teacher preparation program design. It then asserts ... and that decades of input- and outcome-based research has failed to improve teacher ...
(Date:3/28/2017)... ... March 28, 2017 , ... Greenfield Advisors ... brings his extensive knowledge of appraisals, property values, ad valorem taxation, and government ... valuation industry for more than 40 years. , “Ruel is a great addition ...
(Date:3/28/2017)... ... 2017 , ... Dr. Isabella Wentz, PharmD, FASCP, one of the leading thyroid ... Thyroid Secret. Dr. Wentz talked about journey and research recently on a blog and ... NOT the only solution to deal with thyroid disease. , Dr. Wentz completed ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Mar 29, 2017 Research and Markets has ... Forecast to 2023" report to their offering. ... The ablation device global market ... $20,995.5 million by 2023. Ablation is the minimally ... purposes, from cancerous or diseased tissue removal, to the removal of ...
(Date:3/29/2017)... , March 29, 2017   Dynatronics ... today the appointment of Cynthia L. McHenry ... will be responsible for leading Dynatronics manufacturing, distribution, ... will report to Dynatronics, CEO Kelvyn H. ... concludes an extensive search process conducted by the ...
(Date:3/29/2017)... FinancialBuzz.com News Commentary  ... Data published in a research report by Grand View Research, ... of USD 55.8 billion by 2025. The projection takes into consideration the ... and a more open approach towards cannabis products around the world. In ... , North Dakota , Ohio , ...
Breaking Medicine Technology: